Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Marek

Vascular Surgery Albuquerque, NM Medical Doctor

NPI 1447267406 CMS profile 1002450

2Nd Ambulatory Care Ctr, 2211 Lomas Blvd. Ne, Albuquerque, NM 87131

Open in the dashboard

General payments

$3,907

39 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Marek of Albuquerque, NM is reported in the CMS Open Payments database as having received $3,907 across 39 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 44th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $807 16
2024 General $2,124 8
2023 General $166 2
2021 General $16 1
2020 General $222 2
2019 General $572 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Marek
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to John Marek were reported at $807. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year John Marek Vascular Surgery median Middle half National median
2019 $572 $796 $226–$2,363 $163
2020 $222 $348 $118–$1,110 $114
2021 $16 $471 $158–$1,421 $132
2022 $0 $725 $222–$2,183 $149
2023 $166 $836 $257–$2,440 $160
2024 $2,124 $909 $252–$2,619 $164
2025 $807 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Bausch & Lomb Americas Inc. $1,500 1 payment
  2. W. L. Gore & Associates, Inc. $1,307 13 payments
  3. Cook Medical LLC $377 6 payments
  4. LeMaitre Vascular, Inc. $351 7 payments
  5. Penumbra, Inc. $116 2 payments
  6. Janssen Pharmaceuticals, Inc $104 2 payments
  7. Medtronic Vascular, Inc. $35 2 payments
  8. Shape Memory Medical Inc. $29 1 payment
  9. Teleflex LLC $21 1 payment
  10. Maquet Cardiovascular U.S. Sales, L.L.C. $19 1 payment
  11. Other $48 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,357 37 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,500 1 payment
  3. Education $50 1 payment
Products named General payments · program years 2019–2025
  1. enVista MX60 IOL $1,500 1 payment
  2. TENEO $1,500 1 payment
  3. EXCLUDER Conformable AAA Endoprosthesis with Active Control $413 5 payments
  4. EXCLUDER AAA Endoprosthesis $326 3 payments
  5. HYDRO LEMAITRE VALVULOTOME $252 4 payments
  6. GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis $201 2 payments
  7. GORE EXCLUDER Iliac Branch Endoprosthesis $174 1 payment
  8. Conformable TAG Thoracic Endoprosthesis $144 1 payment
  9. Cook Medical Zenith $120 1 payment
  10. XARELTO $104 2 payments
  11. Other $656 18 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$29,544

Medicare's payments for the services billed

Medicare patients

190

Average age 70

Services billed

238

80 women, 110 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 48%
Arthritis 44%
Diabetes 43%
Depression 36%
Ischemic heart disease 34%
Heart failure 31%
Atrial fibrillation 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

39 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record